Leading the way to safer medication
 Crosscheck  Recommender

Everolimus

Description

Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers.

ATC Classification

Code
Title
Category
L01EG02
Everolimus
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L04AA18
Everolimus
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants

Trade names

Trade name
Countries

Austria

Australia Austria Canada Cyprus France

Australia Austria Cyprus France Netherlands

Australia

Austria Cyprus Netherlands

United States

Product Monographs

Monograph
Type
Country
VOTUBIA Dispersible tablets
MPI, EU: SmPC